secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2021-10-26T23:59:59+00:00
Accession:  0001588978-21-000007
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PROCEPT BioRobotics appoints Elisabeth Sandoval to Board of Directors
---------------------------------------------------------------------

- Board expanded from eight to nine members; Sandoval appointed as Class I director effective Oct. 21, 2021.
- Sandoval is a healthcare executive with prior roles at Allergan (20+ years) and as CCO of Kythera Biopharmaceuticals and Alder Biopharmaceuticals.
- She will receive a restricted stock unit award valued at $200,000, vesting over three years.
- Sandoval also serves on boards of Intersect ENT, Satsuma Pharmaceuticals, Vyne Therapeutics, and Alastin Skincare.
- CEO Reza Zadno cited her commercial expertise to accelerate Aquablation therapy adoption for BPH.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000158897821000007/0001588978-21-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000158897821000007/a8-kxelizabethsandoval.htm
  HTML page:      https://secwatch.observer/filing/0001588978-21-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer